CYSLTR1 and multiminicore myopathy: To evaluate the role of leukotriene (LT) receptor signaling in monocytes during HMGB1-induced MMD, BMDCs were stimulated with HMGB1 (100 ng/ml) for 10 days in the presence of various leukotriene receptor inhibitors, including U75302 (a BLTR1 inhibitor), LY255283 (a BLTR2 inhibitor), REV5901 (a cysLTR1 inhibitor), and HAMI3379 (a cysLTR2 inhibitor).